Shareholder Voting Reminder Ahead of Titan's Special Meeting
Important Voting Reminder for Titan Medical Shareholders
TORONTO, Ontario — Titan Medical Inc. (TSX: TMD; OTC: TMDIF) has announced a crucial reminder for its shareholders regarding the voting process for the upcoming annual and special shareholders meeting (the "Meeting"). The Meeting is set to take place on September 30, 2024, and participating in this vote is vital for all shareholders.
Current Voting Status
As it stands, less than half of Titan's common shares have been voted in advance of the Meeting. Shareholders are encouraged to take action and ensure their voices are heard.
Vote Today
It is essential for shareholders to cast their votes promptly. Every vote matters, and your participation can significantly influence the direction of the company. Make your voice count by voting today.
Accessing the Management Information Circular
Details regarding the Meeting can be found in the Management Information Circular (the "Circular"). This important document along with related materials is accessible through Titan’s official website. It's crucial for shareholders to review these documents to fully understand the matters up for vote.
Recording of Shareholders Q&A Session
A recording of the recent Shareholders Q&A session held on September 19, 2024, is available for those who wish to catch up on what has been discussed regarding the company and its future plans. This session provides valuable insights for all stakeholders.
Assistance for Shareholder Questions
Shareholders who have questions or need assistance with the voting process can reach out to Shorecrest Group. They offer support via telephone at 1-888-637-5789 or +1-647-931-7454. For those who prefer email, inquiries can be directed to contact@shorecrestgroup.com.
About Titan Medical Inc.
Titan Medical Inc. is a pioneering medical technology company founded under the Business Corporations Act in Ontario. Headquartered in Toronto, the company has made significant strides in advancing robotic-assisted surgery (RAS). With a comprehensive patent portfolio, Titan is committed to developing and licensing innovative solutions that can transform surgical procedures.
A Look at Conavi Medical
Conavi Medical Inc. stands out in the realm of medical technology, focusing on designing and marketing imaging technologies for enhancing minimally invasive cardiovascular procedures. Their flagship product, the Novasight Hybrid™ System, represents a significant advancement in imaging, combining two critical imaging modalities for improved surgical outcomes. This system has received necessary clearances from regulatory authorities including the FDA and Health Canada, showcasing its credibility in the market.
Frequently Asked Questions
What is Titan Medical Inc. focused on?
Titan Medical is dedicated to enhancing robotic-assisted surgery through innovative technologies and a strong patent portfolio.
How can shareholders vote for the upcoming meeting?
Shareholders can cast their votes as outlined in the Management Information Circular available on Titan’s website.
What should I do if I have questions about the voting process?
Shareholders can contact Shorecrest Group for assistance with any inquiries related to the voting process.
Where can I find more information about Titan Medical's developments?
For the latest developments and updates, shareholders can visit Titan Medical’s official website and check their news section.
Is Conavi Medical also associated with Titan Medical?
While Titan focuses on robotic surgery, Conavi Medical specializes in imaging technologies for cardiovascular procedures, demonstrating the diversity in medical technology advancements.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- MeridianLink's Secondary Common Stock Offering Details Unveiled
- Costco's Strategic Moves to Mitigate Impact of US Port Strikes
- Cue Biopharma Sets $12 Million Public Offering to Fund Growth
- Microsoft's Bold $2.7B Investment to Transform Brazil's AI Landscape
- Cue Biopharma's Innovative Journey: Public Offering Details
- Mark Cuban Offers Insight on Violent Crime Data and Politics
- Discover the New Features of OKX's On-chain Earn Product
- China's August Sees Industrial Profit Drop Amid Economic Concerns
- Tensions Rise as Trump Plans Meeting with Ukraine's Zelenskyy
- Investors Urged to Act Before Deadline on Orthofix Case
Recent Articles
- Exploring Promising Cancer Treatment Stocks for Investors
- Breeze Holdings Merger: Transforming Cancer Diagnostics and Treatment
- Acasti Pharma Completes Enrollment in GTX-104 Phase 3 Trial
- Exploring the Investment Potential in AI Stocks Today
- LuxUrban Hotels Announces Upcoming Webcast for Q2 Insights
- Current State of US Stock Markets and Economic Insights
- Hampton Financial Corporation Welcomes New Leadership at Oxygen
- Ocular Therapeutix Showcases Innovations at Virtual Event
- 23andMe Unveils Revolutionary Insights on Emotional Eating
- Amedisys Celebrates Recognition for Care Excellence in 2023 SHPBest Awards
- InflaRx Highlights Successful Vilobelimab Trial Results
- YieldMax™ ETFs Releases Upcoming Distribution Details
- Thames Ventures VCT 2 PLC Reports Latest Net Asset Values
- NASA and SpaceX Reschedule Crew-9 Mission Amid Weather Concerns
- Seth Farbman Takes the Stage at Lytham Partners' Conference
- Brink’s and Sainsbury’s Forge Partnership to Enhance ATM Services
- OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy
- AGF Management Limited's Impressive Growth in Q3 Results
- Microbix Biosystems Inc. Showcases Innovations at Investor Event
- Abiologics Welcomes New Chief Scientific Officer to Propel Innovation
- AGF Management Limited Announces Q3 2024 Dividend of 11.5 Cents
- Atavistik Bio Welcomes Dr. Mohammad Hirmand to Leadership Team
- Southern Michigan Bancorp Announces Dividend and Future Plans
- Dr. Kira Espiritu Takes Charge as Dean at ACM-IAU
- Upcoming Highlights of the Emerging Growth Conference 2024
- Steakholder Foods' Agreement with Bondor Foods: A New Era for Plant-Based Innovations
- VersaBank Moves to Redeem Series 1 Preferred Shares Successfully
- Altair and Aston Martin Team Up for Eco-Friendly Vehicle Innovation
- Investigation Launched Against Extreme Networks for Fraud Allegations
- Accenture Set to Announce Q4 Results Amid Analyst Adjustments
- Septerna Accelerates Drug Development with Strategic Appointments
- Taylor Morrison Sets Earnings Release Date for Q3 2024
- Vertex Energy Secures $80M Financing Amid Bankruptcy Filing
- CULT Food Science's Noochies! Sprinkles: A Pet Nutrition Breakthrough
- FuelPositive Outlines Key Milestones for Green Ammonia Project
- Berkshire Hathaway's Strategic Move: Recent BofA Share Sales
- Global Payments Faces Analyst Pressure: Future Growth Uncertain
- UniCredit's Bold Strategy Sparks German Regulatory Concerns
- Kamala Harris Expands Support Against Trump Ahead of Election
- Long-Term Efficacy of BIMZELX in Plaque Psoriasis Patients
- Navigating Change: Southwest Airlines' Outlook and Plans
- Astralis Partners with GoWish to Revolutionize Fan Engagement
- Ribbon Communications: Analyzing Growth Prospects and Challenges
- Thermon Group Enhances Leadership to Drive Future Growth
- Finastra Welcomes Andrew Bateman to Boost Lending Sector Growth
- Kymera Therapeutics Advances KT-621: A New Era in Treatment
- Emergent BioSolutions Secures $400 Million Vaccine Orders for 2024
- Vicinity Motor Corp. Faces Financial Challenges Yet Shows Growth
- Morgan Stanley Lowers Rivian Stock Outlook and Insights
- Baird Reaffirms Cautious Stance on Amgen Amid Market Developments